Home > Products > CD19 & CD59 > Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (scFv4-Ig)

Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (scFv4-Ig)  (CAT#: FVTIG-043)

Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CD19 scFv is fused to the CH1 domain of a heavy chain and another anti-CD59 scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can recruit complement to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
Datasheet INQUIRY

Specifications

Targets
CD19 & CD59
Type
Appended IgGs
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma; Leukemia

Targets

Target 1
CD19
Gene ID
UniProt ID
Alternative Names
CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4
Target 2
CD59
Gene ID
UniProt ID
Alternative Names
CD59; CD59 molecule, complement regulatory protein; 1F5; EJ16; EJ30; EL32; G344; MIN1; MIN2; MIN3; MIRL; HRF20; MACIF; MEM43; MIC11; MSK21; 16.3A5; HRF-20; MAC-IP; p18-20; CD59 glycoprotein; protectin; 1F5 antigen; MEM43 antigen; Ly-6-like protein; T cell-activating protein; human leukocyte antigen MIC11; lymphocytic antigen CD59/MEM43; 20 kDa homologous restriction factor; membrane inhibitor of reactive lysis; membrane attack complex inhibition factor; membrane attack complex (MAC) inhibition factor; surface anitgen recognized by monoclonal antibody 16.3A5; CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD19 & CD59"
See other bsAb targets related to "CD19"

See other bsAb targets related to "CD59"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (scFv4-Ig) (FVTIG-043). Click the button below to contact us or submit your feedback about this product.